{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:13:52Z","timestamp":1762542832660,"version":"3.32.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":2282,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1017\/s104161021800011x","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T08:22:40Z","timestamp":1521620560000},"page":"1499-1507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care"],"prefix":"10.1016","volume":"30","author":[{"given":"Stephanie","family":"Behrens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail B.","family":"Rattinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Matyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Scott","family":"DeBerard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine G.","family":"Lyketsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn T.","family":"Tschanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S104161021800011X_bb0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"Alzheimer's disease facts and figures","volume":"12","author":"Alzheimer's Association","year":"2016","journal-title":"Alzheimer's & Dementia"},{"year":"1987","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","key":"10.1017\/S104161021800011X_bb0015"},{"key":"10.1017\/S104161021800011X_bb0020","first-page":"S346","article-title":"Effective pharmacological management of Alzheimer's disease","volume":"17","author":"Atri","year":"2011","journal-title":"The American Journal of Managed Care"},{"key":"10.1017\/S104161021800011X_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.53.2.321","article-title":"APOE-E4 count predicts age when prevalence of AD increases, then declines","volume":"53","author":"Breitner","year":"1999","journal-title":"Neurology"},{"key":"10.1017\/S104161021800011X_bb0030","unstructured":"Bureau of Labor Statistics (2016a). Consumer Price Index. https:\/\/www.bls.gov\/cpi\/."},{"key":"10.1017\/S104161021800011X_bb0035","unstructured":"Bureau of Labor Statistics (2016b). Occupational Employment Statistics. https:\/\/www.bls.gov\/oes\/."},{"key":"10.1017\/S104161021800011X_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archneur.1988.00520250037015","article-title":"Reliability of the Washington university clinical dementia rating","volume":"45","author":"Burke","year":"1988","journal-title":"Archives of Neurology"},{"key":"10.1017\/S104161021800011X_bb0045","first-page":"S142","article-title":"The 2012 update to the anticholinergic cognitive burden scale","volume":"61","author":"Campbell","year":"2013","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S104161021800011X_bb0050","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","article-title":"Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population","volume":"169","author":"Carriere","year":"2009","journal-title":"Archives of Internal Medicine"},{"key":"10.1017\/S104161021800011X_bb0055","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/(SICI)1099-1166(199710)12:10<978::AID-GPS659>3.0.CO;2-1","article-title":"The caregiver activity survey (CAS): Development and validation of a new measure for caregivers of persons with Alzheimer's disease","volume":"12","author":"Davis","year":"1997","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S104161021800011X_bb0060","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.46.6.1746","article-title":"The clinical dementia rating scale: Community-based validation of \u201cprofound' and \u201dterminal' stages","volume":"46","author":"Dooneief","year":"1996","journal-title":"Neurology"},{"key":"10.1017\/S104161021800011X_bb0065","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0140-6736(02)08267-3","article-title":"Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: A randomised trial","volume":"359","author":"Erkinjuntti","year":"2002","journal-title":"Lancet"},{"key":"10.1017\/S104161021800011X_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjopharm.2005.03.005","article-title":"Economics of dementia and pharmacoeconomics","volume":"3","author":"Fillit","year":"2005","journal-title":"The American Journal of Geriatric Pharmacotherapy"},{"key":"10.1017\/S104161021800011X_bb0075","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1532-5415.2007.01387.x","article-title":"Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries","volume":"55","author":"Gruber-Baldini","year":"2007","journal-title":"Journal of American Geriatric Society"},{"key":"10.1017\/S104161021800011X_bb0080","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"55","author":"Hughes","year":"1982","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S104161021800011X_bb0085","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","article-title":"Monetary costs of dementia in the United States","volume":"368","author":"Hurd","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"10.1017\/S104161021800011X_bb0090","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1525-1497.2001.10123.x","article-title":"National estimates of the quantity and cost of informal caregiving for the elderly with dementia","volume":"16","author":"Langa","year":"2001","journal-title":"Journal of General Internal Medicine"},{"key":"10.1017\/S104161021800011X_bb0095","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1017\/S104161021200049X","article-title":"Effects of general medical health on Alzheimer's progression: The cache county dementia progression study","volume":"24","author":"Leoutsakos","year":"2012","journal-title":"International Psychogeriatric"},{"key":"10.1017\/S104161021800011X_bb0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjopharm.2005.07.001","article-title":"Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: A case-control study","volume":"3","author":"Lu","year":"2005","journal-title":"American Journal of Geriatric Pharmacotherapy"},{"key":"10.1017\/S104161021800011X_bb0105","first-page":"656","article-title":"Population-based study of medical comorbidity in early dementia and \u2018Cognitive Impairment No Dementia (CIND)\u2019: Association with functional and cognitive impairment: The cache county study","volume":"13","author":"Lyketsos","year":"2005","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S104161021800011X_bb0110","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1017\/S104161021800011X_bb0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jalz.2011.02.011","article-title":"Effects of food and drug administration-approved medications for Alzheimer's disease on clinical progression","volume":"8","author":"Mielke","year":"2012","journal-title":"Alzheimer's & Dementia"},{"key":"10.1017\/S104161021800011X_bb0120","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/geronb\/gbp052","article-title":"Caregiver-recipient closeness and symptom progression in Alzheimer disease. The cache county dementia progression study","volume":"64","author":"Norton","year":"2009","journal-title":"The Journals of Gerontology. Series B, Psychological Sciences and Social sciences"},{"key":"10.1017\/S104161021800011X_bb0125","first-page":"746","article-title":"Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database","volume":"67","author":"O'Bryant","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1017\/S104161021800011X_bb0130","first-page":"513","article-title":"Effects of post hospital Medicare home health and informal care on patient functional status","volume":"33","author":"Penrod","year":"1998","journal-title":"Health Services Research"},{"key":"10.1017\/S104161021800011X_bb0135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/jgs.12210","article-title":"Pharmacotherapeutic management of dementia across settings of care","volume":"61","author":"Rattinger","year":"2013","journal-title":"Journal of American Geriatric Society"},{"key":"10.1017\/S104161021800011X_bb0140","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jalz.2014.11.004","article-title":"Dementia severity and the longitudinal costs of informal care in the cache county population","volume":"11","author":"Rattinger","year":"2015","journal-title":"Alzheimer's & Dementia"},{"key":"10.1017\/S104161021800011X_bb0145","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jalz.2016.03.008","article-title":"Closer caregiver and care-recipient relationships predict lower informal costs of dementia care:The cache county dementia progression study","volume":"12","author":"Rattinger","year":"2016","journal-title":"Alzheimer's & Dementia"},{"key":"10.1017\/S104161021800011X_bb0150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jalz.2012.01.002","article-title":"Effectiveness of antidementia drugs in delaying Alzheimer's disease progression","volume":"9","author":"Rountree","year":"2013","journal-title":"Alzheimer's & Dementia"},{"year":"2009","series-title":"2009 Mosby's Nursing Drug Reference","author":"Skidmore-Roth","key":"10.1017\/S104161021800011X_bb0155"},{"key":"10.1017\/S104161021800011X_bb0160","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/JGP.0b013e3181faec23","article-title":"Progression of cognitive, functional, and neuropsychiatric symptoms in a population cohort with Alzheimer dementia: The cache county dementia progression study","volume":"19","author":"Tschanz","year":"2011","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S104161021800011X_bb0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jagp.2012.10.005","article-title":"Caregiver coping strategies predict cognitive and functional decline in dementia: The cache county dementia progression study","volume":"21","author":"Tschanz","year":"2013","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S104161021800011X_bb0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpsyc.62.2.217","article-title":"Do statins reduce risk of incident dementia and Alzheimer disease? The cache county study","volume":"62","author":"Zandi","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1017\/S104161021800011X_bb0175","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1532-5415.2006.00871.x","article-title":"Clinical characteristics and longitudinal changes of informal costs of Alzheimer's disease in the community","volume":"54","author":"Zhu","year":"2006","journal-title":"Journal of American Geriatrics Society"},{"key":"10.1017\/S104161021800011X_bb0180","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1212\/01.wnl.0000230160.13272.1b","article-title":"Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease","volume":"67","author":"Zhu","year":"2006","journal-title":"Neurology"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224018209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224018209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S104161021800011X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T13:29:12Z","timestamp":1736515752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224018209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1041610224018209"],"URL":"https:\/\/doi.org\/10.1017\/s104161021800011x","relation":{},"ISSN":["1041-6102"],"issn-type":[{"type":"print","value":"1041-6102"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S104161021800011X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}